Singapore markets closed
  • Straits Times Index

    3,217.41
    +10.42 (+0.32%)
     
  • Nikkei

    31,857.62
    -14.90 (-0.05%)
     
  • Hang Seng

    17,809.66
    +436.63 (+2.51%)
     
  • FTSE 100

    7,608.08
    +6.23 (+0.08%)
     
  • Bitcoin USD

    26,982.18
    +93.63 (+0.35%)
     
  • CMC Crypto 200

    579.66
    +0.90 (+0.15%)
     
  • S&P 500

    4,288.05
    -11.65 (-0.27%)
     
  • Dow

    33,507.50
    -158.84 (-0.47%)
     
  • Nasdaq

    13,219.32
    +18.05 (+0.14%)
     
  • Gold

    1,864.60
    -14.00 (-0.75%)
     
  • Crude Oil

    90.77
    -0.94 (-1.02%)
     
  • 10-Yr Bond

    4.5730
    -0.0240 (-0.52%)
     
  • FTSE Bursa Malaysia

    1,424.17
    -15.94 (-1.11%)
     
  • Jakarta Composite Index

    6,939.89
    +2.06 (+0.03%)
     
  • PSE Index

    6,321.24
    -64.28 (-1.01%)
     

Should Income Investors Buy This Soon-to-Be Dividend King?

Should Income Investors Buy This Soon-to-Be Dividend King?

Imagine spending a lifetime building your investment portfolio only to worry about whether you will outlive the balance in your investment accounts. If you are exclusively buying growth stocks with the intent of eventually selling them off for capital gains to sustain your lifestyle, running out of money could be a possibility. Consider medical device maker Medtronic (NYSE: MDT).